PALUMBO, Antonio

PALUMBO, Antonio  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 454 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA. 2010 Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 2016 Zamagni E.; Nanni C.; Gay F.; Pezzi A.; Patriarca F.; Bello M.; Rambaldi I.; Tacchetti P.; Hillengass J.; Gamberi B.; Pantani L.; Magarotto V.; Versari A.; Offidani M.; Zannetti B.; Carobolante F.; Balma M.; Musto P.; Rensi M.; Mancuso K.; Dimitrakopoulou-Strauss A.; Chauvie S.; Rocchi S.; Fard N.; Marzocchi G.; Storto G.; Ghedini P.; Palumbo A.; Fanti S.; Cavo M.
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. 1984 Pegoraro L; Palumbo A; Erikson J; Falda M; Giovanazzo B; Emanuel BS; Rovera G; Nowell PC; Croce CM.
A comparison of allografting with autografting for newly diagnosed myeloma 2007 BRUNO B; ROTTA M; PATRIARCA F; MORDINI N; ALLIONE B; CARNEVALE-SCHIANCA F; GIACCONE L; SORASIO R; OMEDE P; BALDI I; BRINGHEN S; MASSAIA M; AGLIETTA M; LEVIS A; GALLAMINI A; FANIN R; PALUMBO A; STORB R; CICCONE G; BOCCADORO M
A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients 2010 Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Mosca Siez ML; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M
A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma 2008 Musto P, Petrucci MT, Bringhen S, Guglielmelli T, Caravita T, Bongarzoni V, Andriani A, D'Arena G, Balleari E, Pietrantuono G, Boccadoro M, Palumbo A; GIMEMA (Italian Group for Adult Hematologic Diseases)/Multiple Myeloma Working Party and the Italian Myeloma Network.
A new combination for advanced multiple myeloma. 2011 Palumbo A; Gay F.
A new standard of care for elderly patients with myeloma 2007 PALUMBO A; BOCCADORO M
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 2016 Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A
A Phase 3 Study Evaluating the Efficacy and Safety of Lenalidomide (Len) Combined with Melphalan and Prednisone Followed by Continuous Lenalidomide Maintenance (MPR-R) in Patients (Pts) ≥ 65 Years (Yrs) with Newly Diagnosed Multiple Myeloma (NDMM): Updated Results for Pts Aged 65-75 Yrs Enrolled in MM-015 2011 Palumbo A; Adam Z; Kropff M; Foà R; Catalano J; Gisslinger H; Wiktor-Jedrzejczak W; Delforge M; Weisel K; Cascavilla N; Van Droogenbroeck J; Iosava G; Cavo M; Blade J; Beksac M; Spicka I; Plesner T; Yu Z; Herbein L; Mei J; Jacques CJ; Dimopoulos MA
A PHASE 3 STUDY TO DETERMINE THE EFFICACY AND SAFETY OFLENALIDOMIDE COMBINED WITH MELPHALAN AND PREDNISONE INPATIENTS = 65 YEARS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA(NDMM) 2010 A Palumbo; M Dimopoulos; M Delforge; R Hajek; M Kropff; MT Petrucci; Z Yu; L Herbein; J Mei; C Jacques; J Catalano
A PHASE III STUDY OF ENOXAPARIN VS ASPIRIN AS THROMBOPROPHYLAXIS FOR PATIENTS WITH NEWLY DIAGNOSED OF MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE-BASED REGIMENS. 2011 F. CAVALLO; T. CARAVITA; F. DI RAIMONDO; G. CICCONE; B. LUPO; M. MARCATTI; A. BARALDI; N. PESCOSTA; A.P. FALCONE ;R. RIA; L. BALDINI; L. MASINI; T. GUGLIELMELLI; G. GAIDANO; G. BENEVOLO; C. CANGIALOSI ; M. GALLI ; L. CATALANO; A. LAROCCA; A. NAGLER; M. BOCCADORO; A. PALUMBO
A Phase III Study to Determine the Efficacy and Safety of Lenalidomide in Combination with Melphalan and Prednisone (MPR) in Elderly Patients with Newly Diagnosed Multiple Myeloma 2008 Palumbo A; Dimopoulos MA; Delforge M; Kropff M; Foa R; Yu Z; Herbein L; Mei J; Jacques C; Catalano J
A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo. 2007 B. Bruno; M. Rotta; F. Patriarca; D. Mattei; B. Allione; F. Carnevale-Schianca; A. Rambaldi; M. Casini; V. Montefusco; M. Parma; P. Bavaro; F. Onida; A. Busca; L. Castagna; M.P. Iori; D. Maloney; B. Sandmaier; F. Benedetti; N. Mordini; L. Giaccone; R. Sorasio; F. Fiore; A. Filippi; A. Palumbo; M. Aglietta; A. Levis; R. Foà; P. Di Bartolomeo; E. Pogliani; G. Lambertenghi-Deliliers; M. Falda; M. Petrini; P. Corradini; R. Fanin; U. Ricardi; R. Storb; I. Baldi; and Mario Boccadoro
A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL 2007 Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M
A PROSPECTIVE RANDOMIZED TRIAL OF BORTEZOMIB-MELPHALANPREDNISONE-THALIDOMIDE FOLLOWED BY CONTINUOUS BORTEZOMIB-THALIDOMIDE FOR INITIAL THERAPY OF MULTIPLE MYELOMA:EFFECT OF AGE AND CO-MORBIDITIES 2010 A Palumbo; S Bringhen; D Rossi; M Cavalli; R Ria; M Offidani; C Nozzoli; L Baldini; L De Rosa; G De Sabbata; AM Liberati; C Crippa; F Ciambelli; V Callea; M Spriano; F Ferrara; F Elice; M Galli; J Peccatori; L Catalano; M Rizzo; R Marasca; F Pisani; M Cavo; M Petrucci; P Musto; P Omedè; A Larocca; G Gaidano; M Boccadoro
A Prospective Randomized Trial of Oral Melphalan, Prednisone, Thalidomide (MPT) vs Oral Melphalan, Prednisone (MP): An Interim Analysis. 2004 Palumbo A; Bertola A; Musto P; Caravita T; Callea V; Cangialosi C; Liberati AM; Niscola P; Catalano L; Grasso M; Lauta VM; Petti MC; Morandi S; Galli S; Bringhen S; Cavallo F; Falco P; Boccadoro M
A Prospective, Randomized, Phase III Study of Enoxaparin Versus Aspirin Versus Low-Fixed-Dose of Warfarin in Newly Diagnosed Myeloma Patients Treated with Thalidomide-Containing Regimens. 2007 Palumbo A; Cavo M; Bringhen S; Perrone G; Magarotto V; Patriarca F; Petrucci MT; Galli M; Di Raimondo F; Rossi D; Marasca R; Offidani M; Goldaniga M; Corradini P; Crippa C; Catalano L; Callea V; Gozzini A; Tosi P; Boccadoro M
A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients. 2007 Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients 2013 Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A